Pines Wealth Management LLC Invests $247,000 in Sanofi (NASDAQ:SNY)

Pines Wealth Management LLC bought a new stake in shares of Sanofi (NASDAQ:SNY) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,072 shares of the company’s stock, valued at approximately $247,000.

Other large investors have also added to or reduced their stakes in the company. Northwest Investment Counselors LLC bought a new position in shares of Sanofi during the 3rd quarter worth approximately $29,000. Concord Wealth Partners boosted its stake in Sanofi by 157.8% during the third quarter. Concord Wealth Partners now owns 593 shares of the company’s stock worth $34,000 after acquiring an additional 363 shares in the last quarter. Sunbelt Securities Inc. grew its holdings in Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares during the period. Fortitude Family Office LLC increased its stake in Sanofi by 708.6% in the third quarter. Fortitude Family Office LLC now owns 752 shares of the company’s stock valued at $43,000 after purchasing an additional 659 shares in the last quarter. Finally, UMB Bank n.a. raised its holdings in shares of Sanofi by 39.2% during the third quarter. UMB Bank n.a. now owns 1,073 shares of the company’s stock valued at $62,000 after purchasing an additional 302 shares during the period. Institutional investors and hedge funds own 14.04% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Two investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $57.50.

Sanofi Stock Performance

SNY opened at $49.37 on Thursday. Sanofi has a 1-year low of $45.22 and a 1-year high of $58.97. The company has a market cap of $125.29 billion, a price-to-earnings ratio of 25.19, a PEG ratio of 1.23 and a beta of 0.57. The company’s fifty day moving average price is $48.53 and its two-hundred day moving average price is $52.11. The company has a current ratio of 1.00, a quick ratio of 0.65 and a debt-to-equity ratio of 0.17.

Sanofi (NASDAQ:SNY) last posted its earnings results on Friday, October 25th. The company reported $1.57 earnings per share for the quarter, topping analysts’ consensus estimates of $0.22 by $1.35. The company had revenue of $13.44 billion for the quarter, compared to analyst estimates of $16.59 billion. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. The firm’s revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.55 EPS. On average, analysts expect that Sanofi will post 4.06 EPS for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.